Edye Edens interviews Darshan Kulkarni about the evolution of the Kulkarni Law Firm (KLF). Darshan reflects on how he originally envisioned working with large pharmaceutical and device companies, but over the past 15–20 years, the firm has expanded to support not only pharma, but also law firms, consulting companies, and research sites. They discuss how the clinical research landscape has shifted—from a focus on academic institutions and big players to a broader ecosystem that includes indepe...

Ever wondered about the impact of eating only Pop Rocks for a week? Explore whether this sugary challenge could harm your stomach lining, affect your gut health, or provide enough calories for survival. Timelines of the challenge: 00:00: Introduction to Pop Rocks 01:29: Day One Experiences 02:19: Day Three Check-In 03:07: Day Five Insights 04:30: Day Seven Conclusion Always consult with a health professional for medical advice. This content is for informational purposes only.

During the week of Aug. 5, 2025, we enjoy reports of turtles, otters, and a family of young raccoons. Staff phenologist John Latimer responds.

This week on BioTech Nation, Dr. Eric Topol returns to continue his conversation on, "Super Agers … An Evidenced-Based Approach to Longevity", his evidence-based approach to living longer, healthier lives. He shares why longevity must be accessible to everyone, not just the wealthy, and how new tools like AI, personalized diagnostics, and even gut hormones are reshaping the future of health.

This is a free preview of a paid episode. To hear more, visit www.razibkhan.comToday Razib talks to Noah Millman. Millman is an American screenwriter and filmmaker, as well as a political columnist and cultural critic based in Brooklyn, New York. He is the film and theater critic for Modern Age; previously he was a columnist for The Week (2015–2022) and a senior editor at The American Conservative (2012–2017). Millman writes the newsletter Gideon’s Substack, and his work has also appeared in outlets

shgshsjfjnxnn

The editor-in-chief cited “inconsistencies in the number of subjects” as the reason for the retraction.

Stories of his time as a PhD student borrowing a ute to from UQ to take blood from truckdrivers on the roadside, “Robust discussions with his colleague,” and remembering life when finding the latest published paper was a social occasion. He fondly recalls the people and the work that make us punch above our weight.

Last year, we reported how extreme weather events may be dwindling the future of chocolate. Just last week, we saw an inkling of that: The Hershey Company announced it would significantly raise the cost of its candy in the face of historically high cocoa prices. So, we're revisiting host Emily Kwong's conversation with Yasmin Tayag, a food, health and science writer at The Atlantic. They get into the cocoa shortage: What's causing it, how it's linked to weather and poor farming conditions and what

.taaagaygsddf

>FASTA: weekly short reads of the global biotech ecosystem | Papers and patents, acquisitions and bankruptcies, biotech philosophy | Read in under 5 min | Follow on LinkedIn, X, YouTube, and Instagram! | Versión en EspañolPilgrim is proud to sponsor >FASTA! We’re developing the next generation of military medicine to meet the operational demands of modern warfare—moving beyond theory and bringing biotechnology from the benchtop to the battlefield.1/10: Our sponsor cut open his leg and raised

Estava nas minhas anotações, mas me esqueci de dizer: quando fizemos Twitter Files Brasil, uma crítica do nosso trabalho, que se recusava a comentar as principais revelações e jogava holofote sobre um pequeno erro cometido apenas na versão em inglês (não na versão publicada pela Gazeta do Povo, editada por mim), foi promovida por toda a imprensa alinhada com o regime.Era a advogada Estela Aranha, ex-funcionária do ministro Flávio Dino, o destruidor de livros. Há poucos dias, ela foi confirmada por

The new study challenges a long-held view that the barrel cortex exclusively encodes sensory signals from the whiskers.

Text the Show and Show some LOVE for TR! Once I knew that I was NOT to be within a braid with Sol'Mara & Ma"Lion I cleared all the blurred lines and found my way Back to MY Original Flame, LUCIEN! Soul contracts are messy and not linear, They can and do twist and turn, this is just one possibility and it is what kept me in service to another couple for centuries. Please send questions or comments to fanmail! Support the show

In this QCast episode, join co-hosts Jullia and Tom as they break down Phase 1 clinical trial designs. You’ll learn exactly what happens in single and multiple ascending-dose stages, discover modern dose-escalation methods, and find out how food-effect, interaction and bioequivalence studies fit in. They’ll also share practical strategies for combining objectives, using adaptive protocols and cutting timelines without sacrificing data quality. Key TakeawaysPhase 1 is more than a basic safety check:

Moving from biotech to academiaI recently wrote a piece about leaving academia for biotech.I left academia for industry in 2019. I spent four years at a consulting firm before joining Colossal Biosciences. This week I’m returning to the University of Virginia School of Data Science as a tenured associate professor and dean of research.The transition from academia to industry can be tricky, but it’s also increasingly common. There are far fewer academic jobs available than there are trainees coming

During the week of July 29, 2025, we enjoy reports from Long Lake Conservation Center, Kathleen in Brainerd and more. Staff phenologist John Latimer responds.